AdipoPharma
PrivateLast Round
Series A
Jan 23, 2023
Company Overview
AdipoPharma is a biotechnology company that develops peptide-based therapeutic treatments for insulin resistance and Type 2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AdipoPharma Comparables
Compare AdipoPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adipo Therapeutics | 81% | |
| Antag Therapeutics | 81% | |
| KeyBioscience AG | 77% | |
AdipoPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 23, 2023 |
Key People
Founding team and executive leadership
AdipoPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Good Growth Capital | Series A |
| Okeanos | Series A |
| ORSA | Series A |
| Sambrinvest | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Monthly visitors increased 67% MoM.
- Jan 23, 2023
Led by Newton Biocapital II with participation from Good Growth Capital.
AdipoPharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AdipoPharma's valuation, stock price, and market status.